Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The limits of genome-wide methods for pharmacogenomic testing.

Pharmacogenetics and genomics - 1 Apr 2012

Gamazon Eric R, Skol Andrew D, Perera Minoli A

Abstract excerpt

OBJECTIVE: The goal of pharmacogenomics is the translation of genomic discoveries into individualized patient care. Recent advances in the means to survey human genetic variation are fundamentally transforming our understanding of the genetic basis of interindividual variation in therapeutic resp...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Genetic
Share to Biomarkers, Pharmacological
Share to Genome, Human

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HapMap Project

Share to Inactivation, Metabolic

Share to Linkage Disequilibrium

Share to Pharmacogenetics

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 22344246
DOI: 10.1097/FPC.0b013e328350ca5f
PMCID: PMC3655533

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22344246-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The limits of genome-wide methods for pharmacogenomic testing.PMID 22344246Read ↗

Requirements for comprehensive pharmacogenetic genotyping platforms.Semantic proximity Read ↗

Comparison of genome sequencing and clinical genotyping for pharmacogenesSemantic proximity Read ↗

Pharmacogenomics in the era of next generation sequencing – from byte to bedsideSemantic proximity Read ↗

Genome Sequencing Enhances Precision and Clinical Utility of Pharmacogenetic Data Compared to Arrays.Semantic proximity Read ↗

Whole genome sequencing in pharmacogenomicsSemantic proximity Read ↗

Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response.Semantic proximity Read ↗

Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.Semantic proximity Read ↗

The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.Semantic proximity Read ↗

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.Semantic proximity Read ↗

Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.Semantic proximity Read ↗

Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.Semantic proximity Read ↗

A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.